参考文献/References:
[1] Mapelli M,Musacchio A.The structural perspective on CDK5[J].Neurosignals,2003,12:164-172.
[2]Dhavan R,Tsai L H.A Decade of CDK5[J].Nat Rev Mol Cell Biol,2001,2:749-759.
[3]Zhang B,Su Z C,Tay T E,et al.Mechanism of CDK5 activation revealed by steered molecular dynamics simulations and energy calculations[J].J Mol Model,2010,16:1 159-1 168.
[4]Cicenas J,Valius M.The CDK inhibitors in cancer research and therapy[J].J Cancer Res Clin Oncol,2011,137:1 409-1 418.
[5]Tarricone C,Dhavan R,Peng J.Structure and regulation of the CDK5-p25nck5a complex[J].Mol Cell,2001,8(3):657-669.
[6]Dhariwala F A,Rajadhyaksha M S.An unusual member of the Cdk family:Cdk5[J].Cell Mol Neurobiol,2008,28(3):351-369.
[7]Pitchuanchom S,Boonyarat C,Forli S,et al.Cyclin-dependent kinases 5 template:useful for virtual screening[J].Comput Biol Med,2012,42(1):106-111.
[8]Glicksman M A,Cuny G D,Liu M,et al.New approaches to the discovery of cdk5 inhibitors[J].Curr Alzheimer Res,2007,4(5):547-549.
[9]Leost M,Schultz C,Link A,et al.Paullones are potent inhibitors of glycogen synthase kinase-3β and cyclin-dependent kinase 5/p25[J].Eur J Biochem,2000,267(19):5 983-5 994.
[10]Beauchard A,Ferandin Y,Frère S,et al.Synthesis of novel 5-substituted indirubins as protein kinases inhibitors[J].Bioorg Med Chem,2006,14(18):6 434-6 443.
[11]Chang Y T,Gray N S,Rosania G R,et al.Synthesis and application of functionally diverse 2,6,9-trisubstituted purine libraries as CDK inhibitors[J].Chem Biol,1999,6(6):361-375.
[12]Rzasa R M,Kaller M R,Liu G,et al.Structure-activity relationships of 3,4-dihydro-1H-quinazolin-2-one derivatives as potential CDK5 inhibitors[J].Bioorg Med Chem,2007,15(20):6 574-6 594.
[13]Frisch M J,Trucks,G W,Schlegel H B,et al.Gaussian 09,Revision A.02[M].Wallingford:Gaussian Inc,2009.
[14]Case D A,Cheatham T A,Simmerling C L,et al.AMBER 10[M].San Francisco:University of California,2008.